Skip to content

Spinal anaesthesia comparison with hyperbaric drug in ureteroscopic surgeries

EFFICACY OF INTRATHECAL NALBUPHINE AS AN ADJUVANT TO LEVOBUPIVACAINE HEAVY 0.5 % FOR EVALUATING THE DURATION OF ANALGESIA IN PATIENTS UNDERGOING URETEROSCOPIC SURGERIES - A PROSPECTIVE RANDOMISED CLINICAL STUDY - NA

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/09/057989
Enrollment
50
Registered
2023-09-25
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N99- Intraoperative and postproceduralcomplications and disorders of genitourinary system, not elsewhere classified

Interventions

Intervention1: Group L: Patient will receive 3ml(15mg) of 0.5% levobupivacaine heavy with 0.5 ml of Normal saline intrathecally. Analgesia will be assessed for 30,60,90,120, 150,180 and 210 min Contro

Sponsors

Rajarajeswari medical college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. ASA I and II patients of either sex. 2.Patients aged between 20 to 50 years 3. Patients undergoing elective ureteroscopic surgeries.

Exclusion criteria

Exclusion criteria: 1.Patients with known hypersensitivity to local anaesthetic drugs. 2.Pregnant and lactating women. 3.Patients refusal 4.Local site infection and peripheral vascular disease. 5.Diagnosed to have neurological disease. 6.Patients with severe cardiovascular, respiratory, hepatic and renal disease. 7.Patients with coagulation abnormalities. 8.Patients with previous spine surgeries, and spine abnormalities.

Design outcomes

Primary

MeasureTime frame
To compare the effect of adding 1.6 mg Nalbuphine to 0.5 % Levobupivacaine heavy for ureteroscopic surgeries under spinal anaesthesia for evaluating the duration of analgesia.Timepoint: 0,1,3,5,10 minutes

Secondary

MeasureTime frame
Side effects if anyTimepoint: 0,1,3,5,10 minutes

Countries

India

Contacts

Public ContactDr Karthik GS

Rajarajeswari medical college and hospital

drgskarthik@gmail.com9538220515

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026